Genome-wide Association Analysis of Autoantibody Positivity in Type 1 Diabetes Cases

Overview

Journal PLoS Genet

Specialty Genetics

Date 2011 Aug 11

PMID 21829393

Citations 145

Authors

Vincent Plagnol

Joanna M M Howson

Deborah J Smyth

Neil Walker

Jason P Hafler

Chris Wallace

Helen Stevens

Laura Jackson

Matthew J Simmonds

Polly J Bingley

Stephen C Gough

John A Todd

Affiliations

Soon will be listed here.

Abstract

The genetic basis of autoantibody production is largely unknown outside of associations located in the major histocompatibility complex (MHC) human leukocyte antigen (HLA) region. The aim of this study is the discovery of new genetic associations with autoantibody positivity using genome-wide association scan single nucleotide polymorphism (SNP) data in type 1 diabetes (T1D) patients with autoantibody measurements. We measured two anti-islet autoantibodies, glutamate decarboxylase (GADA, n = 2,506), insulinoma-associated antigen 2 (IA-2A, n = 2,498), antibodies to the autoimmune thyroid (Graves') disease (AITD) autoantigen thyroid peroxidase (TPOA, n = 8,300), and antibodies against gastric parietal cells (PCA, n = 4,328) that are associated with autoimmune gastritis. Two loci passed a stringent genome-wide significance level (p<10(-10)): 1q23/FCRL3 with IA-2A and 9q34/ABO with PCA. Eleven of 52 non-MHC T1D loci showed evidence of association with at least one autoantibody at a false discovery rate of 16%: 16p11/IL27-IA-2A, 2q24/IFIH1-IA-2A and PCA, 2q32/STAT4-TPOA, 10p15/IL2RA-GADA, 6q15/BACH2-TPOA, 21q22/UBASH3A-TPOA, 1p13/PTPN22-TPOA, 2q33/CTLA4-TPOA, 4q27/IL2/TPOA, 15q14/RASGRP1/TPOA, and 12q24/SH2B3-GADA and TPOA. Analysis of the TPOA-associated loci in 2,477 cases with Graves' disease identified two new AITD loci (BACH2 and UBASH3A).

Citing Articles

Protein tyrosine phosphatase non-receptor type 2 (PTPN2) gene polymorphisms (rs2542151, rs7234029) in Egyptian Behçet's disease patients: a preliminary report.

Attia D, Alkaffas M, Eissa M, Rashed L, Khattab R, Elzanaty R Clin Rheumatol. 2024; 43(11):3439-3448.

PMID: 39320556 PMC: 11489223. DOI: 10.1007/s10067-024-07128-7.

A functional variant rs912304 for late-onset T1D risk contributes to islet dysfunction by regulating proinflammatory cytokine-responsive gene STXBP6 expression.

Qian Y, Chen S, Wang Y, Zhang Y, Zhang J, Jiang L BMC Med. 2024; 22(1):357.

PMID: 39227839 PMC: 11373477. DOI: 10.1186/s12916-024-03583-w.

Exploring the multifaceted role of RASGRP1 in disease: immune, neural, metabolic, and oncogenic perspectives.

Fan S, Kang B, Li S, Li W, Chen C, Chen J Cell Cycle. 2024; 23(6):722-746.

PMID: 38865342 PMC: 11229727. DOI: 10.1080/15384101.2024.2366009.

Association of RASGRP1 polymorphism with vascular complications in Chinese diabetic patients with glycemic control and antihypertensive treatment.

Zhou J, Xu B, He F, Shu Y, Chen X, Liu Z Cardiovasc Diabetol. 2024; 23(1):166.

PMID: 38730425 PMC: 11088008. DOI: 10.1186/s12933-024-02267-2.

Role of Tula-Family Proteins in Cell Signaling and Activation: Advances and Challenges.

Tsygankov A Int J Mol Sci. 2024; 25(8).

PMID: 38674019 PMC: 11050124. DOI: 10.3390/ijms25084434.

References

Williams A, Aitken R, Chandler M, Gillespie K, Lampasona V, Bingley P . Autoantibodies to islet antigen-2 are associated with HLA-DRB1*07 and DRB1*09 haplotypes as well as DRB1*04 at onset of type 1 diabetes: the possible role of HLA-DQA in autoimmunity to IA-2. Diabetologia. 2008; 51(8):1444-8. DOI: 10.1007/s00125-008-1047-3. View

Gateva V, Sandling J, Hom G, Taylor K, Chung S, Sun X . A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet. 2009; 41(11):1228-33. PMC: 2925843. DOI: 10.1038/ng.468. View

Kordonouri O, Hartmann R, Charpentier N, Knip M, Danne T, Ilonen J . Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany. Exp Clin Endocrinol Diabetes. 2010; 118(4):245-9. DOI: 10.1055/s-0029-1246213. View

Maier L, Anderson D, Severson C, Baecher-Allan C, Healy B, Liu D . Soluble IL-2RA levels in multiple sclerosis subjects and the effect of soluble IL-2RA on immune responses. J Immunol. 2009; 182(3):1541-7. PMC: 3992946. DOI: 10.4049/jimmunol.182.3.1541. View

Callender S, Langman M, MACLEOD I, MOSBECH J, Nielsen K . ABO blood groups in patients with gastric carcinoma associated with pernicious anaemia. Gut. 1971; 12(6):465-7. PMC: 1411666. DOI: 10.1136/gut.12.6.465. View

Savola K, Sabbah E, Kulmala P, Vahasalo P, Ilonen J, Knip M . Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia. 1998; 41(11):1293-7. DOI: 10.1007/s001250051067. View

McGovern D, Jones M, Taylor K, Marciante K, Yan X, Dubinsky M . Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease. Hum Mol Genet. 2010; 19(17):3468-76. PMC: 2916706. DOI: 10.1093/hmg/ddq248. View

Martin S, Duinkerken G, Scherbaum W, Kolb H, Noordzij J, Roep B . Development of type 1 diabetes despite severe hereditary B-cell deficiency. N Engl J Med. 2001; 345(14):1036-40. DOI: 10.1056/NEJMoa010465. View

Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M . Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol. 2010; 172(11):1280-5. DOI: 10.1093/aje/kwq299. View

10.

Hollowell J, Staehling N, Flanders W, Hannon W, Gunter E, Spencer C . Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002; 87(2):489-99. DOI: 10.1210/jcem.87.2.8182. View

11.

Linden S, Mahdavi J, Semino-Mora C, Olsen C, Carlstedt I, Boren T . Role of ABO secretor status in mucosal innate immunity and H. pylori infection. PLoS Pathog. 2008; 4(1):e2. PMC: 2174967. DOI: 10.1371/journal.ppat.0040002. View

12.

Vandewalle C, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W . Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry. Diabetes Care. 1997; 20(10):1547-52. DOI: 10.2337/diacare.20.10.1547. View

13.

Roep B, Duinkerken G, Schreuder G, Kolb H, de Vries R, Martin S . HLA-associated inverse correlation between T cell and antibody responsiveness to islet autoantigen in recent-onset insulin-dependent diabetes mellitus. Eur J Immunol. 1996; 26(6):1285-9. DOI: 10.1002/eji.1830260616. View

14.

Barrett J, Clayton D, Concannon P, Akolkar B, Cooper J, Erlich H . Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6):703-7. PMC: 2889014. DOI: 10.1038/ng.381. View

15.

Wong F, Wen L, Tang M, Ramanathan M, Visintin I, Daugherty J . Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes. 2004; 53(10):2581-7. DOI: 10.2337/diabetes.53.10.2581. View

16.

Kondrashova A, Viskari H, Haapala A, Seiskari T, Kulmala P, Ilonen J . Serological evidence of thyroid autoimmunity among schoolchildren in two different socioeconomic environments. J Clin Endocrinol Metab. 2007; 93(3):729-34. DOI: 10.1210/jc.2007-1644. View

17.

Knip M, Korhonen S, Kulmala P, Veijola R, Reunanen A, Raitakari O . Prediction of type 1 diabetes in the general population. Diabetes Care. 2010; 33(6):1206-12. PMC: 2875424. DOI: 10.2337/dc09-1040. View

18.

Kochi Y, Yamada R, Suzuki A, Harley J, Shirasawa S, Sawada T . A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat Genet. 2005; 37(5):478-85. PMC: 1362949. DOI: 10.1038/ng1540. View

19.

Mariotti S, Caturegli P, Piccolo P, Barbesino G, Pinchera A . Antithyroid peroxidase autoantibodies in thyroid diseases. J Clin Endocrinol Metab. 1990; 71(3):661-9. DOI: 10.1210/jcem-71-3-661. View

20.

Lindberg B, Carlsson A, Ericsson U, Kockum I, Lernmark A, Landin-Olsson M . Prevalence of beta-cell and thyroid autoantibody positivity in schoolchildren during three-year follow-up. Autoimmunity. 2000; 31(3):175-85. DOI: 10.3109/08916939908994062. View